ARCHIVES

Phase II Study Tests Chemo Plus Mylotarg For AML

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Constance Percy Retires From NCI After 30 Years.

November 10, 2000

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

July 29, 2011

Congressional News: Senate Subcommittee Recommends $2.3 Bil. Budget for NCI

September 13, 1996

Program Announcement For Clinical Research

February 29, 1980

In Brief: Fredrickson Will Stay As NIH Director; NCI Group to Study Rhoads’ Clinical Center Idea

February 11, 1977

Study: Gene Assay Can Provide Valid Prognostic Information

January 31, 2014